HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of two methods for detecting intrathecal synthesis of Borrelia burgdorferi-specific antibodies and PCR for diagnosis of Lyme neuroborreliosis.

Abstract
An indirect immunofluorescence assay (IFA), a commercial capture enzyme-linked immunosorbent assay (ELISA), and PCR were compared for the diagnosis of Lyme neuroborreliosis in 16 individuals. Borrelia burgdorferi-specific intrathecal immunoglobulin G was found in 10 of 16 patients by IFA and in 8 of 12 patients by capture ELISA. PCRs performed on cerebrospinal fluid samples stored at -70 degrees C were positive for one of eight children and one of four adults with intrathecal antibody production and negative for all four adults without intrathecal antibody production. For two children with facial palsy following erythema chronicum migrans, neither IFA nor capture ELISA detected specific intrathecal antibodies and PCR was also negative. We conclude that both clinical manifestations and laboratory parameters are important for the diagnosis of Lyme neuroborreliosis.
AuthorsR Zbinden, D Goldenberger, G M Lucchini, M Altwegg
JournalJournal of clinical microbiology (J Clin Microbiol) Vol. 32 Issue 7 Pg. 1795-8 (Jul 1994) ISSN: 0095-1137 [Print] United States
PMID7929776 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antibodies, Bacterial
  • Immunoglobulin G
Topics
  • Adolescent
  • Adult
  • Aged
  • Antibodies, Bacterial (analysis, blood, cerebrospinal fluid)
  • Antibody Specificity
  • Base Sequence
  • Borrelia burgdorferi Group (immunology)
  • Child
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Fluorescent Antibody Technique
  • Humans
  • Immunoglobulin G (analysis, blood, cerebrospinal fluid)
  • Lyme Disease (blood, cerebrospinal fluid, immunology)
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Polymerase Chain Reaction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: